This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have been unicorns. Currently, he is CEO and Co-Founder of Boston-based Thrive Bioscience, which commercializes instruments and software for a critically important but neglected area of life sciences, which is imaging, analytics, and automation of cell culture, cell-based research, and cell therapeutics.
- Thomas Forest Farb-Horch has experience automating cytology labs and now seeks to improve cell culture labs through Thrive.
- Thrive aims to improve the low chances of therapeutics getting from bench to patient by transforming cell biology.
- Thrive’s technology collects large, comparable data sets that make better cells, which is important for bringing cell therapeutics to the market.
- Thrive’s data sets and images are valuable to researchers because they can see things that they never saw before and make faster decisions.
- Thrive is transforming viral plaque assay, which is the standard way of studying viruses, and can now track plaques from day 2 instead of waiting for weeks.
- Thomas is concerned about divisiveness, duality, and false dualities, and the lack of equality of opportunity, education, and health.
- Thomas is excited about solving big, ignored problems and changing the world.